Table 1 Individual and shared clonal aneusomies of metastases and parental cancers
From: Inherent variability of cancer-specific aneuploidy generates metastases
Primary/Metastasis | Total clonal aneusomies | Aneusomies shared with cancer | Metastasis-specific, clonal aneusomies (% of total) |
|---|---|---|---|
1)Breast, HIM-2 Metastasis, HIM-5 | 23 23 | - 22 | - 1 (4%) |
2)Melanoma, WM-115 Metastasis, WM-266-4 | 30 31 | - 18 | - 13 (42%) |
3)Liver, H2P Metastasis, H2M | 31 31 | - 16 | - 15 (48%) |
4)Medulloblastoma M-458 Metastasis, M-425 | 34 28 | 11 | 17 (61%) |
5)Colon, SW480-C1 Colon SW480-C2 Metastasis, SW620 vs C1 SW620 vs C2 | 38 39 38 38 | - - 13 11 | - - 25 (66%) 27 (71%) |
6)Melanoma, IGR-39 Metastasis, IGR-37 | 30 31 | - 4 | - 27 (87%)a |
7)Pancreas, A13-B Metastases, A13-A and A13-D | 50 49 46 | 22 30 | 27 (55%) 16 (35%) |